Ostia Sciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$393K
- Investors
-
2
Ostia Sciences General Information
Description
Operator of a biotechnology company intended to develop innovative oral probiotics and biotherapeutics for improving global health outcomes. The company offers microbiome-based applications that modulate the microbiome, addressing a range of infectious diseases and immune disorders, enabling customers to experience enhanced oral and respiratory health through the power of beneficial microbes.
Contact Information
Website
www.ostiasciences.caCorporate Office
- 124 Edward Street
- Toronto, Ontario M5G 1G6
- Canada
Corporate Office
- 124 Edward Street
- Toronto, Ontario M5G 1G6
- Canada
Ostia Sciences Timeline
Ostia Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 19-Jul-2025 | $393K | Completed | Generating Revenue | ||
| 3. Seed Round | 01-Oct-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Generating Revenue |
Ostia Sciences Patents
Ostia Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026178627-A1 | Enhanced production of phosphorylated lantibiotics | Pending | 28-Feb-2025 | ||
| WO-2025227220-A1 | S. salivarius strain, lanthipeptides and methods of use | Pending | 03-May-2024 | ||
| EP-4476325-A1 | Lanthipeptides and methods of use | Pending | 10-Feb-2022 | ||
| EP-4476325-A4 | Lanthipeptides and methods of use | Pending | 10-Feb-2022 | ||
| US-20250144168-A1 | Lanthipeptides and methods of use | Pending | 10-Feb-2022 | A61K38/164 |
Ostia Sciences Signals
Ostia Sciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Natural Products Canada | Venture Capital | Minority | ||
| University of Toronto | University |
Ostia Sciences FAQs
-
When was Ostia Sciences founded?
Ostia Sciences was founded in 2019.
-
Where is Ostia Sciences headquartered?
Ostia Sciences is headquartered in Toronto, Canada.
-
What is the size of Ostia Sciences?
Ostia Sciences has 8 total employees.
-
What industry is Ostia Sciences in?
Ostia Sciences’s primary industry is Drug Discovery.
-
Is Ostia Sciences a private or public company?
Ostia Sciences is a Private company.
-
What is Ostia Sciences’s current revenue?
The current revenue for Ostia Sciences is .
-
How much funding has Ostia Sciences raised over time?
Ostia Sciences has raised $1.08M.
-
Who are Ostia Sciences’s investors?
Natural Products Canada and University of Toronto have invested in Ostia Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process